Package 63629-2009-1

{"route": ["ORAL"], "spl_id": "50fa1d94-9a48-4e13-8aa9-4abf3126f533", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["af9d41f5-4658-4487-8811-32a1f8af9384"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (63629-2009-1)", "package_ndc": "63629-2009-1", "marketing_start_date": "20210216"}], "brand_name": "Acyclovir", "product_id": "63629-2009_50fa1d94-9a48-4e13-8aa9-4abf3126f533", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63629-2009", "generic_name": "Acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA206261", "marketing_category": "ANDA", "marketing_start_date": "20170817", "listing_expiration_date": "20261231"}